[1]
“HemoTypeSCTM Point-of-care Testing as a Screening Tool for Sickle Cell Disease among Newborns in Ilesa, Nigeria”, Niger J Paediatr, vol. 53, no. 1, pp. 20–27, May 2026, doi: 10.63270/njp.v53i1.2000045.